Health and Fitness Health and Fitness
Thu, February 2, 2012
[ Thu, Feb 02nd 2012 ] - Market Wire
CML HealthCare Appoints Thomas Wellner as CEO
[ Thu, Feb 02nd 2012 ] - Market Wire
Neurocrine Biosciences Announces Conference Call .. ourth Quarter and Year-End 2011 Financial Results
[ Thu, Feb 02nd 2012 ] - Market Wire
Spherix Announces Registered Direct Offering of $1.15 Million
[ Thu, Feb 02nd 2012 ] - Market Wire
Dyer &;; Berens LLP Announces Class Act .. l Technologies Investors;; Encourages Larg
[ Thu, Feb 02nd 2012 ] - Market Wire
Federman &;; Sherwood Announces That a .. uit Has Been Filed Against Columbia Laboratories,
[ Thu, Feb 02nd 2012 ] - Market Wire
Bull amp;; Lifshitz, LLP Announces Investigation of Micromet, Inc.
[ Thu, Feb 02nd 2012 ] - Market Wire
Solta Medical to Report Fourth Quarter 2011 Resul .. s Release and Host Conference Call on February 13
[ Thu, Feb 02nd 2012 ] - Market Wire
Bull & Lifshitz, LLP Announces Investigation of Micromet, Inc.
[ Thu, Feb 02nd 2012 ] - Market Wire
MethylGene Announces the Appointment of Dr. Henry J. Fuchs to its Board of Directors
[ Thu, Feb 02nd 2012 ] - Market Wire
MissionIR Features AdCare Health Systems in Exclu .. Interview Featuring President and CEO Boyd Gentry
[ Thu, Feb 02nd 2012 ] - Market Wire
Cambrex to Announce Fourth Quarter 2011 Financial Results on February 6, 2012
[ Thu, Feb 02nd 2012 ] - Market Wire
International Drug amp;; Explosives Detect .. Company IDenta Corp. Targets New American Markets
[ Thu, Feb 02nd 2012 ] - Market Wire
International Drug & Explosives Detection Company IDenta Corp. Targets New American Markets
[ Thu, Feb 02nd 2012 ] - Market Wire
VentriPoint Launches Updated Version of VMS(TM) Heart Analysis System in Europe and Canada
[ Thu, Feb 02nd 2012 ] - Market Wire
Pro-Dex, Inc. Announces Fiscal 2012 Second Quarter Financial Results Conference Call and Webcast
[ Thu, Feb 02nd 2012 ] - Market Wire
Vista Partners Publishes February 2012 Newsletter
[ Thu, Feb 02nd 2012 ] - Market Wire
Prana Comments on Nature Medicine, PNAS and Journ .. icles That Highlight the Role of Metals in Neurol
[ Thu, Feb 02nd 2012 ] - Market Wire
Dynavax Reports on Heplisav(TM) Pre-BLA Meeting With FDA
[ Thu, Feb 02nd 2012 ] - Market Wire
2012 Economic Outlook - Report Highlights Valeant .. aceuticals Int (USA) and The Dow Chemical Company
[ Thu, Feb 02nd 2012 ] - Market Wire
OncoSec's President and CEO Explains His Firm's Ambitious List of Milestones for 2012
[ Thu, Feb 02nd 2012 ] - Market Wire
$30 Million Due to MMRGlobal Under Non-Exclusive Patent License Agreement
[ Thu, Feb 02nd 2012 ] - Market Wire
CryoLife Announces Release Date and Teleconferenc .. 011 Fourth Quarter and Year End Financial Results
[ Thu, Feb 02nd 2012 ] - Market Wire
AVI BioPharma to Present Company Overview at the .. Annual BIO CEO &;; Investor Conference
[ Thu, Feb 02nd 2012 ] - Market Wire
Cytomedix Announces Option Extension With Top 20 .. and Intent to Proceed to License Agreement for t
[ Thu, Feb 02nd 2012 ] - Market Wire
The Methodist Hospital to Pioneer Vascular Research With Hansen Medical Vascular Robotic System
[ Thu, Feb 02nd 2012 ] - Market Wire
Equity Research on Amgen Inc. and Biogen Idec Inc. - Biotech Industry Growing
[ Thu, Feb 02nd 2012 ] - Market Wire
YouTube Interview Now Available for Kedem Pharmac .. i Updating Company Progress on Sublingual Drug De
[ Thu, Feb 02nd 2012 ] - Market Wire
Discovery Labs Cleared to Market AFECTAIR in U.S.
[ Thu, Feb 02nd 2012 ] - Market Wire
Mylan Receives Tentative FDA Approval for Generic Version of Lipitor
[ Thu, Feb 02nd 2012 ] - Market Wire
Horizon Pharma to Present at the 14th Annual BIO CEO and Investor Conference

Horizon Pharma to Present at the 14th Annual BIO CEO and Investor Conference


Published on 2012-02-02 04:40:05 - Market Wire
  Print publication without navigation


February 02, 2012 07:30 ET

Horizon Pharma to Present at the 14th Annual BIO CEO and Investor Conference

DEERFIELD, IL--(Marketwire - Feb 2, 2012) - Horizon Pharma, Inc. (NASDAQ: [ HZNP ]) today announced that Timothy P. Walbert, chairman, president and chief executive officer, is scheduled to present at the 14th Annual BIO CEO and Investor Conference on Tuesday, February 14, 2012 at 1:30pm Eastern Time in New York, NY. Mr. Walbert will provide an overview of the Company and its corporate activities.

The presentation will be webcast live and may be accessed by visiting Horizon's website at [ http://ir.horizon-pharma.com ]. A replay of the webcast will be available for 10 business days.

About Horizon Pharma
Horizon Pharma, Inc. is a biopharmaceutical company that is developing and commercializing innovative medicines to target unmet therapeutic needs in arthritis, pain and inflammatory diseases. For more information, please visit [ www.horizonpharma.com ].


Contributing Sources